2 deals
Elixinol Wellness strikes $3.5m deal to acquire personalised vitamin platform Vitable
Elixinol has agreed an all-share takeover of supplement subscription platform Vitable at a $2.5 million headline value plus earn-out, while shareholder Ben McHarg commits a convertible note; the piece also recaps Vitable's earlier raises.